Johnson David Michael
Zentalis Pharmaceuticals, Inc. · Director
Johnson David Michael is listed in filings as Director at Zentalis Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 18, 2025, including purchase activity. Recent filings connect the profile to Zentalis Pharmaceuticals, Inc. (ZNTL) and Aura Biosciences, Inc. (AURA). The current snapshot covers public activity from Jun 21, 2024 to Jun 18, 2025. Reported amounts are shown as $105.1K to $24.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $98k20k shares | BuyMay 16, 2025 | $4.90 | $6.89 | |
| $25k5k shares | BuyMay 16, 2025 | $4.90 | $6.89 |